Our prior findings show an association between loss of perivascular AQP4 localization and impairment in glymphatic function in the aging, post-traumatic, and ischemic brain [13–15], yet these studies did not directly test whether this loss of perivascular localization reduces CSF-ISF exchange or alters the development of AD pathology. The gene discussed is AQP4; the disease is Alzheimer disease.